Navigation Links
Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011
Date:2/15/2011

THE WOODLANDS, Texas, Feb. 15, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, will release its fourth quarter and year end 2010 financial results on Thursday, February 24, 2011 before the financial markets open.  Lexicon management will hold a conference call and webcast to discuss clinical development progress and financial results for fourth quarter and year end 2010 at 11:00 a.m. Eastern Time on February 24, 2011.  

The dial-in number for the conference call is 888-220-1244 (within the US/Canada) or 706-679-5615 (international).  The conference ID for all callers is 44537933.  Investors can access a live webcast of the call at www.lexpharma.com.  An archived version of the webcast will be available on the website through March 24, 2011.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking" statements, including statements relating to Lexicon's gro
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
2. Lexicon Pharmaceuticals to Present at the 29th Annual JPMorgan Healthcare Conference
3. Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
4. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
5. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
6. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results
7. Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
8. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
9. Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
10. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
11. Lexicon to Present at BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... N.C. , Aug. 29, 2014 The ... of regulatory and marketplace changes. CI leaders who adjust ... In a new Best Practices, LLC study ... of actionable insights, including: - Use secondary ... than primary research - Internal staff who ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PRNewswire/ ... Medina Medical as CEO and member of the Board ... three decades of medical device development and commercialization experience, ... Medical,s field. Mr. Engelson previously served as a Partner ... served as President and CEO of two Foundry start-ups. ...
(Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2US CNS Disorders Drug Pipeline Insight 2014 2
... 23 SurgiCount Medical, the wholly-owned operating subsidiary ... PSTX ), announced that results of ... Clinic on their multi-year effort to reduce retained ... two upcoming conferences.  The research and related discussion ...
... Agreement to Develop and... -- ABBOTT PARK, Ill. and IRVING, Texas, Sept. 23 ... ... --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Medicine Technology:Mayo Clinic Research on SurgiCount To Be Presented at Conferences 2Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 2Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 3Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 4Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 5Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 6Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 7Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 8Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 9
(Date:8/29/2014)... August 29, 2014 As reported by WKMS.com ... Recovery , an Ohio municipal court drug has come up ... Fred Moses, who serves as the presiding judge in a ... makers to offer addicts a medicated treatment option that can ... the drug known as Vivitrol, which blocks receptors in the ...
(Date:8/29/2014)... 29, 2014 According to new research presented ... Peer Pressure, Key to Prescription Drug Misuse Among Young Adults ... for 18-29 year olds when it comes to prescription drug ... this age group the real problem which influences misuse of ... and recreational use of them to have fun with other ...
(Date:8/29/2014)... Dallas, Texas (PRWEB) August 30, 2014 ... Glass microfiber Industry, 2009-2019 is a professional and ... microfiber industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, Production value, and market ...
(Date:8/29/2014)... 2014 Healthpointe has unveiled its new ... the convenience of visiting with physicians online. Anyone can ... , Healthpointe doctors are always available and happy to ... the doctor can even see the patient’s entire family. ... or she can prescribe medications that are available for ...
(Date:8/29/2014)... August 29, 2014 Healthpointe is ... University Physical Therapy students via Clinical Rotations. ... will be shadowing Healthpointe providers and specialists throughout ... to develop clinical experience and learn professional preparation. ... will gain insight into several patient care techniques ...
Breaking Medicine News(10 mins):Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2
... , BOYNTON BEACH, Fla. , Feb. ... of this year,s US Open Men,s and Women,s tennis tournament ... http://www.newscom.com/cgi-bin/prnh/20100209/DC52484 ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20100120/DC41252LOGO-b ) , Would you ... Golf tournament, complete with airfare and accommodations? , Would you ...
... INDIANAPOLIS -- In the first large-scale epidemiological study of ... researchers from the Indiana University School of Medicine and ... 2010 issue of The Journal of Trauma Injury, ... and opportunities for prevention of these injuries. Nearly ...
... Medical Center are offering pediatric patients diagnosed with chronic ... negative side effects like nausea, fatigue, and vomiting caused ... confluence of Chinese and Western medicine at Rush Children,s ... document how acupuncture might help in reducing pain in ...
... ... Collection Manager™ increases patient safety through accuracy and timeliness , ... (PRWEB) February 9, 2010 ... outreach solutions, announced today that the University of Virginia Health System Medical Laboratories, ...
... D begins in the womb, expert says, , TUESDAY, Feb. ... lots of milk and have a high dietary intake of ... developing multiple sclerosis later in life, researchers say. , The ... about their experiences and diet during pregnancy. The nurses were ...
... , Consumer Watchdog Also Warns Against Insurer-favored ,Cost Solution,: ... Apartment" , WASHINGTON , Feb. 9 ... its premium hikes of up to 39% in California , ... House and an investigation by California ,s insurance commissioner, federal ...
Cached Medicine News:Health News:Would You Like to Own a Thriller Album Autographed by Michael Jackson Himself? 2Health News:Watch your step: Elevator-related injuries and older adults 2Health News:Watch your step: Elevator-related injuries and older adults 3Health News:Young patients with chronic illnesses find relief in acupuncture 2Health News:University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution 2Health News:University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution 3Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 2Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 3
... RAM Scientifics SAFE-T-FILL Capillary Blood Collection ... systems. Available for a wide range of ... with a capillary tube, attached cap and ... action to draw the blood into the ...
... RAM Scientifics SAFE-T-FILL Capillary Blood Collection Tubes ... Available for a wide range of applications, ... a capillary tube, attached cap and a ... to draw the blood into the micro ...
... Toxoplasmosis has progressed from the ... test to immunoflourescence, latex and ... In addition to Toxo IgG ... Toxo IgM immunocapture and indirect ...
... an enzyme immunoassay test in a microwell format. ... incubation. The results are objective and normalized ... The Bio-Rad Measles IgG test is intended for ... antibodies to measles virus in human serum by ...
Medicine Products: